Bionano Genomics, Inc. (BNGO) Form S-3/A — Oct 30, 2026
Bionano Genomics filed Amendment No. 1 to its Form S-3, refreshing a $400,000,000 universal shelf covering common stock, preferred stock, debt securities, warrants and units. The filing carries forward $3,941,645.77 of unsold capacity from its expiring May 2023 shelf under Rule 415(a)(6), with BNGO paying a nominal $342.92 additional fee. The shelf itself is not an actual offering, but it positions Bionano to raise capital at any time via underwritten deals, direct sales, or at-the-market offerings (an ATM agreement with H.C.
Key figures
- Gross Proceeds
- $3,941,645.77 of securities sold under the prior registration statement since initial S-3 filing
- Offering Price
- $1.21 per share (last reported sale price October 28, 2026)
- Shares Offered
- Up to $400,000,000 aggregate of common stock, preferred stock, debt securities, warrants and/or units
- Ib6 limit
- One-third of public float per 12 months while float below $75.0 million
- Net fee due
- $342.92
- Public float
- $25,582,638.72
- Registration fee
- $34,579.48
- Prior shelf file number
- 333-270459
- Ib6 sales prior 12 months
- $5,944,305
- Shares outstanding non affiliates
- 13979584
AI analysis
Red flags6 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.